Unlike current therapies that primarily manage blood sugar levels, this approach would allow doctors to directly target beta cell loss, which could improve long-term disease outcomes for their ...

Beta cells produce and release insulin, the hormone that regulates blood sugar. "Beta-cell failure is responsible for the ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a ...

A panelist discusses how type 1 diabetes (T1D) is a complex autoimmune disease characterized by progressive beta cell destruction that advances through distinct stages, with genetic predisposition, ...

Unlike current therapies that primarily manage blood sugar levels, this approach would allow doctors to directly target beta cell loss, which could improve long-term disease outcomes for their ...

Unlike current therapies that primarily manage blood sugar levels, this approach would allow doctors to directly target beta cell loss, which could improve long-term disease outcomes for their ...

Otonkoski lab is interested in nuclear reprogramming and genome editing, and how these can be applied to understand mechanisms behind pancreatic beta-cell failure leading to diabetes. We also operate ...

Unlike current therapies that primarily manage blood sugar levels, this approach would allow doctors to directly target beta cell loss, which could improve long-term disease outcomes for their ...

Unlike current therapies that primarily manage blood sugar levels, this approach would allow doctors to directly target beta cell loss, which could improve long-term disease outcomes for their ...